LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site (Qty 25), Product Code: SET-0013-25. for intravenous infusion.
Published September 11, 2024 · Recall initiated: August 1, 2024
Summary
FDA records medical device Class I recall Z-2721-2024, published September 11, 2024 and initiated August 1, 2024. Recalling firm: Fresenius Kabi USA, LLC; Status: Ongoing; Reported quantity: 180 cases/4,500 pieces; Lot: Product Code: SET-0013-25; UDI-DI: 00811505030054; Lot number: 3010538. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A defect may cause an uncontrolled medication flow condition which may result in a dose greater than prescribed for the patient (i.e., medication overdose).
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- US Distribution to states of: CO, ID, NJ, UT.
- Lot
- Product Code: SET-0013-25; UDI-DI: 00811505030054; Lot number: 3010538.
- Risk classification
- Class I
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDATyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by FreseniusSeptember 2, 2026
- FDAMorphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular orAugust 26, 2026
- FDAGlycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only,July 29, 2026
- FDAXylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL,July 29, 2026
- FDAVivo 45 LS, pressure and volume ventilator capable of delivering continuous or intermittent ventilatorySeptember 11, 2024
- FDATrilogy Evo EV300 -- Model Number/ Model Description: BL2200X15B Trilogy Evo, O2, Benelux EV300; BR2200X18BSeptember 11, 2024
Questions about this recall
Was LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site (Qty 25), Product Code: SET-0013-25. for intravenous infusion. recalled?
Yes. FDA published recall Z-2721-2024 on September 11, 2024. Reported hazard: A defect may cause an uncontrolled medication flow condition which may result in a dose greater than prescribed for the patient (i.e., medication overdose).
What should I do if I have this product?
Voluntary: Firm initiated · Telephone